Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila M Galloway

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Environmental and Molecular Mutagenesis|March 17, 2017
International regulatory requirements for genotoxicity testing for pharmaceuticals used in human medicine, and their impurities and metabolitesSheila M Galloway
Environmental and Molecular Mutagenesis|December 25, 2008
Sheldon Wolff 1928-2008Jeffrey L Schwartz, Sheila M Galloway, William F Morgan
Regulatory Toxicology and Pharmacology : RTP|May 22, 2013
Potentially mutagenic impurities: analysis of structural classes and carcinogenic potencies of chemical intermediates in pharmaceutical syntheses supports alternative methods to the default TTC for calculating safe levels of impuritiesSheila M Galloway, M Vijayaraj Reddy, Katherine McGettigan, et al.
Mutation Research|December 19, 2006
Chromosome aberrations in Chinese hamster and human cells: a comparison using compounds with various genotoxicity profilesCathy Hilliard, Rosina Hill, Michael Armstrong, et al.
Environmental and Molecular Mutagenesis|January 27, 2004
Population doubling: a simple and more accurate estimation of cell growth suppression in the in vitro assay for chromosomal aberrations that reduces irrelevant positive resultsSusan K Greenwood, Rosina B Hill, Joan T Sun, et al.
Nucleic Acid Therapeutics|March 16, 2016
OSWG Recommendations for Genotoxicity Testing of Novel Oligonucleotide-Based TherapeuticsCindy L Berman, Scott A Barros, Sheila M Galloway, et al.
Environmental and Molecular Mutagenesis|February 1, 2019
Predictions of genotoxic potential, mode of action, molecular targets, and potency via a tiered multiflow® assay data analysis strategyStephen D Dertinger, Andrew R Kraynak, Ryan P Wheeldon, et al.
Toxicologic Pathology|August 25, 2009
A data-based assessment of alternative strategies for identification of potential human cancer hazardsAlan R Boobis, Samuel M Cohen, Nancy G Doerrer, et al.
Journal of Medicinal Chemistry|February 18, 2005
Synthesis and evaluation of S-acyl-2-thioethyl esters of modified nucleoside 5'-monophosphates as inhibitors of hepatitis C virus RNA replicationThazha P Prakash, Marija Prhavc, Anne B Eldrup, et al.
Environmental and Molecular Mutagenesis|September 5, 2002
Genotoxicity of naturally occurring indole compounds: correlation between covalent DNA binding and other genotoxicity testsM Vijayaraj Reddy, Richard D Storer, George M Laws, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Environmental and Molecular Mutagenesis|March 17, 2017
International regulatory requirements for genotoxicity testing for pharmaceuticals used in human medicine, and their impurities and metabolitesSheila M Galloway
Environmental and Molecular Mutagenesis|December 25, 2008
Sheldon Wolff 1928-2008Jeffrey L Schwartz, Sheila M Galloway, William F Morgan
Regulatory Toxicology and Pharmacology : RTP|May 22, 2013
Potentially mutagenic impurities: analysis of structural classes and carcinogenic potencies of chemical intermediates in pharmaceutical syntheses supports alternative methods to the default TTC for calculating safe levels of impuritiesSheila M Galloway, M Vijayaraj Reddy, Katherine McGettigan, et al.
Mutation Research|December 19, 2006
Chromosome aberrations in Chinese hamster and human cells: a comparison using compounds with various genotoxicity profilesCathy Hilliard, Rosina Hill, Michael Armstrong, et al.
Environmental and Molecular Mutagenesis|January 27, 2004
Population doubling: a simple and more accurate estimation of cell growth suppression in the in vitro assay for chromosomal aberrations that reduces irrelevant positive resultsSusan K Greenwood, Rosina B Hill, Joan T Sun, et al.
Nucleic Acid Therapeutics|March 16, 2016
OSWG Recommendations for Genotoxicity Testing of Novel Oligonucleotide-Based TherapeuticsCindy L Berman, Scott A Barros, Sheila M Galloway, et al.
Environmental and Molecular Mutagenesis|February 1, 2019
Predictions of genotoxic potential, mode of action, molecular targets, and potency via a tiered multiflow® assay data analysis strategyStephen D Dertinger, Andrew R Kraynak, Ryan P Wheeldon, et al.
Toxicologic Pathology|August 25, 2009
A data-based assessment of alternative strategies for identification of potential human cancer hazardsAlan R Boobis, Samuel M Cohen, Nancy G Doerrer, et al.
Journal of Medicinal Chemistry|February 18, 2005
Synthesis and evaluation of S-acyl-2-thioethyl esters of modified nucleoside 5'-monophosphates as inhibitors of hepatitis C virus RNA replicationThazha P Prakash, Marija Prhavc, Anne B Eldrup, et al.
Environmental and Molecular Mutagenesis|September 5, 2002
Genotoxicity of naturally occurring indole compounds: correlation between covalent DNA binding and other genotoxicity testsM Vijayaraj Reddy, Richard D Storer, George M Laws, et al.
Pageof 2